Psychotic and Manic Symptoms Associated with Pseudoephedrine, Dextromethorphan, and Caffeine

Introduction to Risks

The combination of pseudoephedrine, dextromethorphan, and caffeine can cause psychosis and manic-like symptoms, particularly in excessive doses or in vulnerable individuals, with the risk substantially amplified when these stimulants are combined, as warned by the Journal of Allergy and Clinical Immunology 1, 2, 3

Pseudoephedrine, as an α-adrenergic agonist, has documented associations with agitated psychosis, ataxia, and hallucinations, especially in young children but also in adults at higher doses, according to the Journal of Allergy and Clinical Immunology 1
The Journal of Allergy and Clinical Immunology guidelines explicitly warn that oral decongestants in infants and young children have been associated with agitated psychosis, ataxia, hallucinations, and even death 1, 2, 3
Even at recommended doses, pseudoephedrine can cause increased stimulatory effects resulting in tachyarrhythmias, insomnia, and hyperactivity, particularly when combined with other stimulant medications, as noted by the Journal of Allergy and Clinical Immunology 2, 3

The concomitant use of caffeine with oral decongestants like pseudoephedrine is associated with additive adverse effects, as stated by the Journal of Allergy and Clinical Immunology 1, 2, 3
The Journal of Allergy and Clinical Immunology guidelines specifically state that concomitant use of caffeine and stimulants may be associated with an increase in adverse events 2, 3

Children under 6 years of age are at the highest risk for agitated psychosis even at recommended doses, according to the Journal of Allergy and Clinical Immunology 1, 2, 3
Individuals with pre-existing psychiatric conditions, such as psychotic disorders, bipolar disorder, and anxiety disorders, are at higher risk, as noted by Praxis Medical Insights 4

Immediate discontinuation of all three agents is the first-line intervention for suspected drug-induced psychosis or mania, as recommended by Praxis Medical Insights 5, 6
Substance-induced psychosis typically resolves within a certain period after discontinuation of the offending agent, according to Praxis Medical Insights 5
Provide patient and family education about the psychiatric risks of these commonly available OTC medications, as suggested by Praxis Medical Insights 4